Eastland Medical Commences Production of Safe Veterinary Needle - VetLok
Eastland Medical Systems Ltd this week commenced production of the new and unique Safe Veterinary Device "VetLok".
Companies in the News
Medical Equipment
First Human Implant of HeartWare's HVAD
On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the Vienna General Hospital and the surgical team was led by Dr Georg Wieselthaler, Clinical Director of Mechanical Circulatory Support at the University of Vienna.
Eastland moves to production phase of 'Retralok'
Eastland Medical Systems Ltd (Eastland) is pleased to announce the completion of their newly designed tooling for the production of their speciality safety syringe Retralok.
Cygenics Biotech Awarded Cell Culture Spinner Flask Patent
Leading cell therapy services company CyGenics Ltd. (ASX: CYN) announced that its US-based subsidiary, Cytomatrix LLC, had been granted US Patent 6991933, Cell Culture Spinner Flasks. This patent adds to the five already granted to the CyGenics group. A number of other patents are pending.
Eastland Medical Systems to Commence ClipOn Needle Production
Eastland Medical Systems (ASX: EMS) is now nearing completion of commercial tooling for production of its ClipOn "Safe" needle device. Production is scheduled to commence in mid February 2006 at Eastland's Portland facility in Victoria and shipments for hospital trials in Australia, South Africa and the United Kingdom will follow shortly thereafter.
Clinical Cell Culture Clarifies Approval Process in Australia
Friday 23 December 2005: Clinical Cell Culture Ltd (C3, ASX: CCE) Clinical Cell Culture (ASX: CCE) would like to clarify aspects of its application for approval to sell its ReCell tissue engineering device in Australia following media comments by the Therapeutic Goods Administration (TGA).
Verna Group to sell Ritract Safety Syringe in UK and Ireland
Ritract Limited is pleased to announce that it has signed a Letter of Intent with the Verna Group to sell and distribute Ritract products in the United Kingdom and Ireland under the well-established Vernacare brand.
◂Previous Page
Medical Equipment Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Managing Director and CEO Commencement Date
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Canadian Patent Secured for PromarkerEso Test for Esophageal Adenocarcinoma
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of CEO and Managing Director
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
Social Media
